中国生化药物杂志2017,Vol.37Issue(8) :183-184,188.DOI:10.3969/j.issn.1005-1678.2017.08.075

米力农治疗小儿先天性心脏病并发重症肺炎及心力衰竭的临床效果

Clinical study of milrinone in the treatment of children with congenital heart disease complicated by severe pneumonia and heart failu

鲍金芳 翁小斌 季坚卫
中国生化药物杂志2017,Vol.37Issue(8) :183-184,188.DOI:10.3969/j.issn.1005-1678.2017.08.075

米力农治疗小儿先天性心脏病并发重症肺炎及心力衰竭的临床效果

Clinical study of milrinone in the treatment of children with congenital heart disease complicated by severe pneumonia and heart failu

鲍金芳 1翁小斌 1季坚卫1
扫码查看

作者信息

  • 1. 义乌市中心医院 小儿科,浙江 义乌 322000
  • 折叠

摘要

目的 探讨米力农治疗小儿先天性心脏病并发重症肺炎及心力衰竭的临床应用效果.方法 选择2014年3月~2016年2月在义乌市中心医院接受治疗先天性心脏病并发重症肺炎及心力衰竭94例作为研究对象,将其分为实验组与常规组,各47例.常规组患儿采用常规治疗手段,实验组患儿在采用常规组相同的常规治疗基础上给予米力农进行治疗.对比2组患者的临床疗效、症状消失时间以及不良反应发生状况.结果 实验组患儿的治疗总有效率(93.62%)显著高于常规组患儿的治疗总有效率(78.72%),差异具有统计学意义(P<0.05);实验组患儿在发热,咳嗽、啰音等症状消失时间上低于常规组,各项数据差异具有统计学意义(P<0.05);2组患儿在治疗过程中均未发生任何严重不良反应,不良反应发生状况差异无统计学意义.结论 米力农治疗小儿先天性心脏病并发重症肺炎及心力衰竭的临床应用效果显著,临床疗效好,不良反应发生率低,值得推广.

Abstract

Objective To investigate the clinical effect of milrinone in the treatment of children with congenital heart disease complicated by severe pneumonia and heart failure. Methods 94 patients with congenital heart disease complicated with severe pneumonia and heart failure in our hospital from March 2014 to February 2016 were selected,and randomly divided into experimental group and routine group,47 cases in each groups. The routine group were treated with conventional treatment, the experimental group in the conventional group received routine treatment based on the same given milrinone treatment. The clinical efficacy, symptom disappearance time and adverse reactions were compared between the two groups. Results The treatment in the experimental group the total efficiency (93.62%) was significantly higher than that of the conventional treatment group with the total effective rate (78.72%), significant difference, statistically significant (P<0.05); the experimental group in children with fever, cough, rales and other symptoms disappeared time is lower than the conventional group, the data had significant difference, has statistical significance (P<0.05); two groups of patients during treatment were not any serious adverse reactions, the adverse reaction condition no difference does not have statistical significance.Conclusion The clinical effect of milrinone in the treatment of children with congenital heart disease complicated by severe pneumonia and heart failure significantly, clinical efficacy, low incidence of adverse reactions, worthy of promotion.

关键词

米力农/小儿先天性心脏病/重症肺炎/心力衰竭/临床疗效

Key words

milrinone/congenital heart disease/severe pneumonia/heart failure/clinical curative effect

引用本文复制引用

出版年

2017
中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
被引量14
参考文献量11
段落导航相关论文